Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk- A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice)
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1182
https://www.valueinhealthjournal.com/article/S1098-3015(15)03258-1/fulltext
Title :
Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk- A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03258-1&doi=10.1016/j.jval.2015.09.1182
First page :
A459
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
681